JBS logged a lower third-quarter profit, citing a difficult operating environment across several business units. The stock fell 7.3% to $12.16 after-hours.
Hims & Hers Health narrowed its sales outlook and reported an unexpected loss in the third quarter, driven by higher costs. The stock was off 2.8% at $22.30.
Skydance detailed plans to cut at least $6 billion in annual costs after its deal to combine Paramount and Warner Bros. Discovery, as the company's third-quarter revenue came in below analyst expectations. Shares were down 2.1% at $8.52 after Monday's closing bell.
Rocket Lab posted a wider-than-expected loss in the third quarter. Shares declined 6.6% to $55.00.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.